Although Apc mutations are infrequently detected [20], mutations in GSK-3β phosphorylation consensus sites on β-catenin are present in up to 77% of AOM-induced colon cancers as well as in early preneoplastic lesions [17, 21–23]. This evidence concerns the gene APC and malignant colon neoplasm.